C12N 2720/12332
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2720/12332 (Use of virus as therapeutic agent, other than vaccine) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 4
- Assignees
- 6
- Inventors
- 11
- Latest grant
- 24 Jul 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 0 | 2 |
| 2009 | 0 | 1 |
| 2010 | 2 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
By publication year.
Recent patents
- Methods for preparing inactivated rotavirus24 Jul 2018US 10,030,232 B2Elanco Tiergesundheit AG
- Homogeneous attenuated human rotavirus population7 Sep 2010US 7,790,179 B2Glaxosmithkline Biologicals SA
- Immunogenic composition of a homogeneous live attenuated human rotavirus population7 Sep 2010US 7,790,180 B2Glaxosmithkline Biologicals SA
- Vaccine23 Oct 2007US 7,285,280 B1SmithKline Beecham Biologicals s.a.
Most cited
By later US patents